[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2012, Vol. 10 ›› Issue (7): 800-806.doi: 10.3736/jcim20120711

• Original Experimental Research • Previous Articles     Next Articles

Effects of Chinese herbal medicine Neiyi Recipe-medicated serum on angiopoiesis of endometriosis in the chick chorioallantoic membrane model

Ling Xu1, Qiao-ling Zhou1, Jie Han1, Dan-ying Zhang1, Hui-juan Dong1, Zai-long Cai2, Chao-qin Yu1(), Dong-xia Zhai1()   

  1. 1. Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
    2. Experimental Research Center, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
  • Received:2011-11-14 Accepted:2011-12-20 Online:2012-07-20 Published:2018-07-15
  • Contact: Yu Chao-qin,Zhai Dong-xia E-mail:chqyu81@gmail.com;zhaidongx@163.com

RichHTML

1

PDF (PC)

79

Like

Objective: To compare angiopoiesis ability of eutopic and ectopic endometrial tissue isolated from women with endometriosis and endometrium isolated from women without endometriosis (control), and to explore the inhibitory effects of medicated serum of Neiyi Recipe, a compound traditional Chinese herbal medicine.
Methods: Chick chorioallantoic membrane (CAM) model of endometriosis was established by transplanting endometrium onto CAM. The CAMs were then hatched with blank serum or medicated serum of danazol or Neiyi Recipe, which were prepared in rats by orally administering. The sizes of the transplanted tissue and new vessels around the transplanted tissue were measured. Expression of vascular endothelial growth factor (VEGF) was detected by immunohistochemical method.
Results: There was no difference in the sizes of transplanted tissue among CAM models of ectopic and eutopic endometrial tissue isolated from women with endometriosis or control (P>0.05), and more new vessels were found around the ectopic and eutopic endometrial tissue than the endometrial tissue of control (P<0.05). Compared with the controls, the size of the transplanted tissue and positive area of new vessels were significantly inhibited by Neiyi Recipe-medicated serum (P<0.01, P<0.05), and similar changes happened in the danazol groups, except for the size of transplanted tissue from ectopic endometrial tissue (P>0.05). Expression of VEGF was significantly higher in eutopic and ectopic endometrial tissue than in the control (P<0.01); the level of VEGF obviously reduced in the Neiyi Recipe and danazol groups (P<0.01), but no significant difference was detected between them.
Conclusion: Endometrium from women with endometriosis stimulates the formation of new vessels by increase the expression of VEGF. Neiyi Recipe-medicated serum significantly decreases the expression of VEGF in eutopic and ectopic endometrial tissues and thus restrains the formation of new vessels, reduces the blood supply and inhibits growth of ectopic endometrial tissue, which are similar to danazol, but has greater efficacy in suppressing the expression of VEGF.

Key words: endometriosis, chorioallantoic membrane, vascular endothelial growth factor, drugs, Chinese herbal, angiogenesis inhibitors

Table 1

Sizes of transplanted tissue and changes after intervention in different groups (x±s)"

Group n Size of transplanted tissue (cm2）
Blank control 5 1.176±0.527
Eutopic control 5 1.502±0.211
Eutopic Neiyi Recipe serum 5 0.730±0.185△△
Eutopic danazol serum 5 0.728±0.144△△
Ectopic control 5 1.240±0.218
Ectopic Neiyi Recipe serum 5 0.517±0.201▲
Ectopic danazol serum 5 0.660±0.363

Table 2

Area of new vessels around the transplanted tissue in different groups (x±s)"

Group n Area of new vessels (%)
Blank control 4 9.84±0.89
Eutopic control 4 12.40±1.90
Eutopic Neiyi Recipe serum 4 6.03±0.4△△
Eutopic danazol serum 4 6.08±0.73△△
Ectopic control 4 13.12±1.87*
Ectopic Neiyi Recipe serum 4 6.79±1.47▲▲
Ectopic danazol serum 4 6.06±2.11▲▲

Table 3

Positive expression index and area ratio of VEGF in different groups (x±s)"

Group n Positive area ratio (%) Optical density Positive expression index
Blank control 6 4.57±1.97 12.00±1.67 56.44±28.37
Eutopic control 6 16.33±1.39 15.33±1.03 249.62±15.53**
Eutopic Neiyi Recipe serum 6 5.61±2.04 12.67±0.82 69.91±22.21△△
Eutopic danazol serum 6 4.51±0.94 13.00±0.63 58.80±14.03△△
Ectopic control 6 17.97±4.22 17.83±2.59 320.39±82.12**
Ectopic Neiyi Recipe serum 6 5.60±0.89 12.83±0.98 71.74±11.86△△□
Ectopic danazol serum 6 11.02±0.66 14.50±0.84 160.00±15.77

Figure 1

VEGF expression in CAM planting focal observed by immunohistochemical method (Light microscopy, ×200) A: Blank control group; B: Eutopic control group; C: Ectopic control group; D: Eutopic Neiyi Recipe serum group; E: Eutopic danazol serum group; F: Ectopic Neiyi Recipe serum group; G: Ectopic danazol serum group. VEGF: vascular endothelial growth factor; CAM: chorioallantoic membrane."

[1] Yu CQ, Shi SF, Liu YH, Wang RX, Song YH, Yu J . Primary culture and morphologic observation of eutopic and ectopic endometrial cells from patients with endomehiosis[J]. J Chin Integr Med, 2006,4(2):189-193
俞超芹, 石书芳, 刘玉环, 王瑞霞, 宋艳华, 俞瑾 . 人子宫内膜异位症在位和异位内膜细胞原代培养及形态学观察[J]. 中西医结合学报, 2006,4(2):189-193
[2] Gaetje R, Kotzian S, Herrmann G, Baumann R, Starzinski-Powitz A . Invasiveness of endometriotic cells in vitro[J]. Lancet, 1995,346(8988):1463-1464
doi: 10.1016/S0140-6736(95)92474-4 pmid: 7490993
[3] Amalinei C, Caruntu ID, Giusca SE, Balan RA . Matrix metalloproteinases involvement in pathologic conditions[J]. Rom J Morphol Embryol, 2010,51(2):215-228
doi: 10.1071/RD10084 pmid: 20495735
[4] Matsuzaki S, Maleysson E, Darcha C . Analysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis[J]. Hum Reprod, 2010,25(3):742-750
doi: 10.1093/humrep/dep435
[5] Juhasz-Bss I, Hofele A, Lattrich C, Buchholz S, Ortmann O, Malik E . Matrix metalloproteinase messenger RNA expression in human endometriosis grafts cultured on a chicken chorioallantoic membrane[J]. Fertil Steril, 2010,94(1):40-45
doi: 10.1016/j.fertnstert.2009.02.052
[6] Sharpe-Timms KL, Penney LL, Zimmer RL, Wright JA, Zhang Y, Surewicz K . Partial purification and amino acid sequence analysis of endometriosis protein-Ⅱ(ENDO-Ⅱ) reveals homology with tissue inhibitor of metalloproteinases-1(TIMP-1)[J]. J Clin Endocrinol Metab, 1995,80(12):3784-3787
[7] McLaren J . Vascular endothelial growth factor and endometriotic angiogenesis[J]. Hum Reprod Update, 2000,6(1):45-55
doi: 10.1093/humupd/6.1.45 pmid: 10711829
[8] Han YH, Zhou YF, Zheng SR . Study on the expression of vascular endothelial growth factor in patients with adenomyosis of the uterus[J]. Zhonghua Fu Chan Ke Za Zhi, 2002,37(9):539-541
doi: 10.3760/j.issn:0529-567X.2002.09.009
韩燕华, 周应芳, 郑淑蓉 . 子宫腺肌病患者血管内皮生长因子表达的研究[J]. 中华妇产科杂志, 2002,37(9):539-541
doi: 10.3760/j.issn:0529-567X.2002.09.009
[9] Tan XJ, Lang JH, Liu DY, Shen K, Leng JH, Sun DW, Liu ZF, Zhu L, Xu XY . Expression of vascular endothelial growth factor and thrombospondin-1 in the ectopic and eutopic endometrium of women with endometriosis[J]. Zhonghua Fu Chan Ke Za Zhi, 2001,36(12):727-730
doi: 10.3760/j.issn:0529-567X.2001.12.007
谭先杰, 郎景和, 刘东远, 沈铿, 冷金花, 孙大为, 刘珠凤, 朱兰, 许秀英 . 血管内皮生长因子及血小板反应素在异位子宫内膜组织中的表达[J]. 中华妇产科杂志, 2001,36(12):727-730
doi: 10.3760/j.issn:0529-567X.2001.12.007
[10] Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, Jaffe RB, Taylor RN . Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis[J]. J Clin Endocrinol Metab, 1996,81(8):3112-3118
[11] Lin J, Gu Y . Effect of monocyte chemoattractant protein-1 and estradiol on the secretion of vascular endothelial growth factor in endometrial stromal cells in vitro[J]. Fertil Steril, 2005,84(6):1793-1796
doi: 10.1016/j.fertnstert.2005.03.090
[12] Kressin P, Wolber EM, Wodrich H , Meyhöfer-Malik A, Buchweitz O, Diedrich K, Malik E .Vascular endothelial growth factor mRNA in eutopic and ectopic endometrium[J]. Fertil Steril, 2001,76(6):1220-1224
doi: 10.1016/S0015-0282(01)02898-9 pmid: 11730754
[13] Yu CQ, Zhai MF, Yao RM, Hu ZZ . Effect of Nei-Yi recipe on plasma β-endorpin level during menstrual cycle in women with endometriosis[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 1995,15(1):6-8
doi: 10.7661/CJIM.1995.1.6
俞超芹, 翟美芙, 姚韧敏, 胡增珍 . 子宫内膜异位症患者性周期β-内啡肽变化及中药内异方对其的影响[J]. 中国中西医结合杂志, 1995,15(1):6-8
doi: 10.7661/CJIM.1995.1.6
[14] Yu CQ, Liu YH, Peng XP, Li J, Pan RP, Ling CQ . IL-8 and IL-10 levels in endometriosis and regulated role of Neiyifang on them[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2000,20(8):603-605
doi: 10.7661/CJIM.2000.8.603
俞超芹, 刘玉环, 彭新萍, 李瑾, 潘瑞萍, 凌昌全 . 子宫内膜异位症白细胞介素-8与白细胞介素-10水平及内异方对其调节作用[J]. 中国中西医结合杂志, 2000,20(8):603-605
doi: 10.7661/CJIM.2000.8.603
[15] Yu C, Cai Z, Liu Y, Wang D, Wang Z . Study on therapeutic mechanism of Neiyifang in treating endometriosis[J]. Chin J Integr Med, 2003,9(2):88-92
doi: 10.1007/BF02838554
[16] Yu CQ, Yu J, Han J, Zhou QL, Shen W . Regulatory mechanism of malignant behavior of endometriosis mediated by puerarin[J]. J Chin Integr Med, 2009,7(1):41-47
doi: 10.3736/jcim20090106
俞超芹, 俞瑾, 韩洁, 周巧玲, 沈慰 . 葛根素对子宫内膜异位症细胞恶性行为调控机制研究[J]. 中西医结合学报, 2009,7(1):41-47
doi: 10.3736/jcim20090106
[1] Jian-sheng Li, Ya Li, Su-yun Li, Yuan-yuan Wang, Li Deng, Yan-ge Tian, Su-li Jiang , Ying Wang. Long-term effects of Tiaobu Feishen therapies on systemic and local inflammation responses in rats with stable chronic obstructive pulmonary disease. Journal of Chinese Integrative Medicine, 2012, 10(9): 1039-1048.
[2] Lu Yu, Shui-miao Lin, Ru-qian Zhou, Wei-jun Tang, Pin-xian Huang, Ying Dong, Jian Wang, Zhi-hua Yu, Jiu-lin Chen, Li Wei, San-li Xing, Hui-juan Cao, Hong-bin Zhao. Chinese herbal medicine for patients with mild to moderate Alzheimer disease based on syndrome differentiation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(7): 766-776.
[3] Dong-mei Zhang, Li-xia Lou, Ai-ming Wu, Xi-ying Lü, Zhao-juan Hu, Yan-hong Zhang, Hong-fang Liu. Effects of Astragalus membranaceus and Potentilla discolor mixture on insulin resistance and its related mRNA expressions in KKAy mice with type 2 diabetes. Journal of Chinese Integrative Medicine, 2012, 10(7): 821-826.
[4] Mei-jiao Mao, Jun-ping Hu, Cong Wang, Yi-yi Zhang, Ping Liu. Effects of Chinese herbal medicine Guanxinkang on expression of PPARγ-LXRα-ABCA1 pathway in ApoE-knockout mice with atherosclerosis. Journal of Chinese Integrative Medicine, 2012, 10(7): 814-820.
[5] Yi-tao Zhao , Xin-guang Zhang , Li Bai , Li-qing Li , Jian-er Yu . Effects of Chinese herbal medicine Pingchuan Formula on airway inflammation, interferon-γ and interleukin-4 in mice with asthma. Journal of Chinese Integrative Medicine, 2012, 10(7): 807-813.
[6] Shui-qiu Deng, Xue-nong Ouyang, Zong-yang Yu, Xi-hu Dai, Xi Chen, Fang-zheng Fang, Wen-wu Wang, Zhi-zhen Liu. Influence of Chinese herbal medicine Feitai Capsule on completion or delay of chemotherapy in patients with stage ⅢB/Ⅳ non-small-cell lung cancer: a Randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 635-640.
[7] Chuan Chen, Hui-ying Chi, Zhi-hua Yu, Jiu-lin Chen . Effects of Chinese herbal medicine Shoushen Granule on telomere length and telomerase activity of peripheral white blood cells and vascular cells in rats with atherosclerosis. Journal of Chinese Integrative Medicine, 2012, 10(6): 667-673.
[8] Hui Luo, Jian-ping Liu, Qing Li. Methodological issues and suggestions for improvement in randomized controlled trials of Chinese herbal medicine for recurrent miscarriage. Journal of Chinese Integrative Medicine, 2012, 10(6): 604-614.
[9] Daniel A. Weber, Janelle M. Wheat , Geoffrey M. Currie. Cancer stem cells and the impact of Chinese herbs, isolates and other complementary medical botanicals: A review. Journal of Chinese Integrative Medicine, 2012, 10(5): 493-503.
[10] Qing-lan Wang, Yan-yan Tao , Li Shen , Hong-yan Cui , Cheng-hai Liu. Chinese herbal medicine Fuzheng Huayu recipe inhibits liver fibrosis by mediating the transforming growth factor-β1/Smads signaling pathway. Journal of Chinese Integrative Medicine, 2012, 10(5): 561-568.
[11] Jing Guo, Ju-yong Wang, Zhan Zheng, Qing Wang, Chang-sheng Dong . Effects of Chinese herbal medicine Feiyanning Decoction on the ratio of CD4+CD25+ regulatory T cells and expression of transcription factor Foxp3 in mice bearing Lewis lung carcinoma. Journal of Chinese Integrative Medicine, 2012, 10(5): 584-590.
[12] Zhan gheng, Ju-yong Wang, Qing Wang, Ling Xu, Zhen-ye Xu. Effects of Chinese herbal medicine Feiyanning decoction on expressions of nucleosome conformation-regulating factors H3-K56, Rtt109, Asf1 and E2F1 in Lewis-bearing mice. Journal of Chinese Integrative Medicine, 2012, 10(4): 448-453.
[13] Gang Guo, Jian-hua Xu, Jian-hong Han, Fang Liang, Yong Zhang, Qiang Zhang, Jue Sun, Zhong-ze Fan . Chinese herbal decoction Shiquan Dabu Tang inhibits tumor growth and angiogenesis of metastasis after primary tumor surgical removal in mice. Journal of Chinese Integrative Medicine, 2012, 10(4): 436-447.
[14] Ying-chun Miao , Jin-zhou Tian , Jing Shi , Min Mao. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: A randomized, double-blind and parallel-controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(4): 390-397.
[15] Na Mu-hai, Yao Cheng-zeng, Yu Xiao-tian, Jiang Mei-xian. Effects of added therapy with Chinese herbal medicine Kanli Granule on skeletal muscle dysfunction in patients with chronic heart failure. Journal of Chinese Integrative Medicine, 2012, 10(3): 324-329.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239
[an error occurred while processing this directive]